Healthcare
Phreesia, Inc.(PHR)
Live Price
Offline$9.38
+0.32% today
1Y Change
-65.40%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- $590.00M
- Revenue Growth
- +14.5%
- EPS Growth
- +103.8%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Phreesia, Inc. (PHR) is a Healthcare stock with a market cap of $590.00M and listed on NYSE. The stock last traded around $9.38 and down 65.4% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +14.5%, EPS growth of +103.8%, a dividend yield of 0.0%. What stands out right now is revenue +14.5%, EPS +103.8%, free cash flow +716.6% with operating margin -1.4% and ROIC 0.3%. Valuation already assumes a fairly strong business story at P/E 250.5 and price/sales 1.2. Stock Foundry combines PHR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+14.5% vs +7.6% peer median
Operating Margin
Below sector median
-1.4% vs +19.4% peer median
P/E
Above sector median
250.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 27, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +14.5% and EPS at +103.8%, with operating margin around -1.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -10.6% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 27, 2026 | โ | +3.5% | +5.7% | โ |
2026 Mar 30, 2026 | +82.6% | -26.6% | -20.6% | -17.4% |
2025 Dec 8, 2025 | +27877.8% | -23.3% | -17.0% | -16.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PHR
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PHR Max Drawdown
-75.24%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PHR and SPY.
Company Overview
Phreesia, Inc.
New York Stock Exchange
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
- Leadership
- Chaim Indig
- IPO Date
- Jul 18, 2019
- Employees
- 2.1k
- Street Address
- 434 Fayetteville Street
- Mailing
- Wilmington, NC, 27601
- Region
- Wilmington, NC, US
- Reporting Currency
- USD
- Investor Line
- 888 654 7473
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 250.5
- EV/EBITDA
- 20.9
- Price/Sales
- 1.2
- Price/Book
- 1.7
Growth
- Revenue
- +14.5%
- EPS
- +103.8%
- Free Cash Flow
- +716.6%
Profitability
- Gross Margin
- 61.3%
- Operating Margin
- -1.4%
- Net Margin
- 0.5%
- ROE
- 0.7%
- ROIC
- 0.3%
Balance Sheet
- Debt/Equity
- 0.30
- Current Ratio
- 1.53
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.